--- title: "Celebrus Technologies updates share capital after treasury share buyback" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/277589315.md" description: "Celebrus Technologies has completed a share buyback of 15,000 ordinary shares at an average price of 130.95 pence, now holding 1,179,240 shares in treasury. This reduces the free float and updates the share capital structure, impacting voting rights to 39,252,213. Analysts rate the stock as a Hold with a £156.00 price target, noting strong profitability but challenges with revenue decline and cash flow. The company focuses on real-time data technology for various sectors and has a market cap of £51.64M." datetime: "2026-03-03T08:49:47.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277589315.md) - [en](https://longbridge.com/en/news/277589315.md) - [zh-HK](https://longbridge.com/zh-HK/news/277589315.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/277589315.md) | [English](https://longbridge.com/en/news/277589315.md) # Celebrus Technologies updates share capital after treasury share buyback ### Claim 50% Off TipRanks Premium - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The latest update is out from Celebrus Technologies ( (GB:CLBS) ). Celebrus Technologies has conducted a share buyback, purchasing 15,000 ordinary shares at a volume-weighted average price of 130.95 pence per share, with the shares to be held in treasury. Following this transaction, the company has 40,431,453 ordinary shares in issue, of which 1,179,240 are held in treasury, resulting in 39,252,213 voting rights for the purposes of shareholder disclosure calculations. The update clarifies the new share capital and voting rights structure, giving investors an accurate denominator for assessing whether they must report holdings under UK disclosure rules. The move marginally reduces the free float and may signal management’s confidence in the company’s valuation while tightening the share base, which can be relevant for liquidity and future capital management decisions. The most recent analyst rating on (GB:CLBS) stock is a Hold with a £156.00 price target. To see the full list of analyst forecasts on Celebrus Technologies stock, see the GB:CLBS Stock Forecast page. **Spark’s Take on GB:CLBS Stock** According to Spark, TipRanks’ AI Analyst, GB:CLBS is a Neutral. Celebrus Technologies’ strong profitability and solid balance sheet are offset by revenue decline and negative cash flow trends. The stock’s technical indicators suggest a bearish trend, while valuation metrics are reasonable. The earnings call provides a balanced outlook with growth in ARR and a strong cash position, but challenges remain with revenue recognition and reported losses. To see Spark’s full report on GB:CLBS stock, click here. **More about Celebrus Technologies** Celebrus Technologies plc is a data technology company focused on helping brands improve customer relationships through real-time, first-party data. Its flagship Celebrus platform captures, contextualises, and activates user behavioural data across digital channels for clients in financial services, retail, travel, healthcare, and telecoms in over 27 countries. The group also offers Celebrus Cloud, an enterprise platform to optimise use of its software, with operations in the UK, US, and India and compliance with major data privacy regulations, including ISO27001 accreditation. **Average Trading Volume:** 105,226 **Technical Sentiment Signal:** Sell **Current Market Cap:** £51.64M See more data about CLBS stock on TipRanks’ Stock Analysis page. ## 相關資訊與研究 - [3 Best Tech Stocks to Buy Now, According to Citi's Top-Rated Analyst](https://longbridge.com/zh-HK/news/280353843.md) - [ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad](https://longbridge.com/zh-HK/news/280337821.md) - [BUZZ-Nanobiotix jumps after media report says J&J mulls potential takeover](https://longbridge.com/zh-HK/news/280444847.md) - [SpaceX aims to file for IPO as soon as this week, The Information reports](https://longbridge.com/zh-HK/news/280386478.md) - [Lilly plots European discontinuations of certain insulin products](https://longbridge.com/zh-HK/news/280344700.md)